Analysis-Middle East war disrupts pharma air routes, risks cancer drugs supply

The Middle East war, triggered by US and Israeli strikes on Iran and subsequent Iranian regional counterstrikes, is disrupting pharmaceutical air supply chains to the Gulf region, endangering supplies of cancer drugs and other temperature-sensitive medicines. Key air transit hubs have been knocked out and shipping routes closed, forcing companies to seek costly rerouting options. Industry executives warn of severe risks to patient care across the region.